News & Events

News &

Tarsier® Pharma receives certificate of registration for trademark Tarsier® in the US & other territories

26 June, 2022

Tarsier Pharma is pleased to announce that on June 21, 2022, the US Patent and Trademark Office has registered Tarsier® as its trademark, namely for ophthalmic drugs. This follows registration of the trademark in other territories.

BizDev Manager, Ruti Friedel, commented: “as a step in strengthening our brand, and for optimal international reach of our products, Tarsier® Pharma has applied for protection of its trademark Tarsier® in international markets. We are glad to have it registered now also in the US, as this would be one of our major markets for our drug candidates.”

Scroll to Top